Home Medicine Foam sclerotherapy during shunt surgery for portal hypertension and varices
Article Open Access

Foam sclerotherapy during shunt surgery for portal hypertension and varices

  • Zhe Zhang , Xueming Chen , Chenyu Li , Hai Feng , Hongzhi Yu , Renming Zhu and Tianyou Wang EMAIL logo
Published/Copyright: November 22, 2017

Abstract

Objective

This preliminary study investigated the clinical safety and efficacy of foam sclerotherapy during shunt surgery to treat portal hypertension and gastroesophageal varices.

Methods

Seven patients with confirmed portal hypertension and a variceal bleeding history underwent mesocaval shunt with simultaneous polidocanol foam injection into the varices. Computed tomography and endoscopic reviews were conducted within two weeks following the procedures and around six months later.

Results

Six patients underwent side-to-side mesocaval shunt. One received a prosthetic mesocaval shunt. Polidocanol foam was injected into the gastric varices or the inferior mesenteric vein during the surgery. Surgical success and survival was achieved in all patients. Gastric ulcer formation and thrombocytopenia occurred in one patient respectively, which were ameliorated by conservative treatment. During 12 to 24 months’ follow-up, three patients had obvious decrease or eradication of gastroesophageal varices; four patients had obvious decrease of gastric varices but residual esophageal varices; and all patents had unobstructed shunts. Encephalopathy occurred in one patient two months postoperatively. No sclerosant-related complications were observed and no postoperative recurrent variceal bleeding occurred.

Conclusions

Foam sclerotherapy during shunt surgery is safe and effective for portal hypertension and varices treatment.

1 Introduction

Portal hypertension is a clinical syndrome that occurs when there is an increased resistance to blood flow in the portal venous system, causing the elevation in the pressure gradient between the portal vein and the inferior vena cava [1]. Portal hypertension can cause gastroesophageal varices and lead to variceal bleeding, which can be life threatening unless effectively controlled. Despite advancement in diagnostics and treatment, the mortality rate of patients with acute variceal hemorrhage can reach to 15-20% [2,3].

Currently, management of portal hypertension involves diverse treatments with drugs, endoscopic therapy, interventional therapy, surgery, and liver transplantation. Although minimal invasive treatments are developing rapidly, they have their limits. Endoscopic variceal ligation and endoscopic sclerotherapy are the first line treatments for acute gastroesophageal variceal bleeding or hemorrhage prophylaxis [4,5]. However, endoscopic therapy cannot reduce the high pressure of the portal venous system, and subsequent variceal re-bleeding may occur [6]. The transjugular intrahepatic portal–systemic shunt (TIPS) is an effective method to reduce portal venous pressure when endoscopy fails but this has a relatively high occlusion rate [7]. One other minimal invasive procedure is Balloon-occluded retrograde transvenous obliteration using foam sclerosant to control hemorrhage, however the method requires an autogenous gastrorenal shunt. Evidence indicates that the role of surgery including shunt surgeries and devascularization still cannot be replaced, especially in extra-hepatic portal hypertension [8,9].

To date, the management of portal hypertension and its complications requires a multidisciplinary approach. To take advantage of current treatments, we conducted this study to evaluate the safety and efficacy of our modified operation by combining shunt surgery with foam sclerotherapy.

2 Material and methods

2.1 Patients

Nine consecutive patients diagnosed with portal hypertension and gastroesophageal varices, between February 2015 to January 2016, were considered for shunt surgery combined with foam sclerotherapy.

Inclusion criteria were the following: 1. Portal hypertension and varices confirmed by sonography, contrast-enhanced computed tomography (CT), and endoscopy; 2. Previous failure of endoscopic treatment or other interventional treatment; or repeated variceal hemorrhage; 3. Child-Pugh class A or B liver function.

Exclusion criteria were: 1. Combined serious comorbidities; 2. Patient refused surgery. Two patients were excluded because one was complicated with renal carcinoma requiring simultaneous partial nephrectomy; the other refused operation. The other seven patients underwent shunt surgery combined with foam sclerotherapy and comprised the study group. Their medical records were retrospectively analyzed (Table 1).

Table 1

Clinical characteristics of patients

Patient No.Age (y)SexDiagnosisVaricesChild-Pugh classPrevious variceal bleedingPrevious treatment
158maleportal cavernomaesophageal and gastricAyesmedication
260maleportal cavernomaesophageal and gastricAyesendoscopic therapy
361femaleBudd-Chiari syndromeesophageal and gastricAyesmedication
440malecirrhosisesophageal and gastricAyesinterventional embolization
544maleportal venous thrombosisesophageal, gastric and rectalAyesdevascularization and endoscopic therapy
634maleportal cavernomaesophageal and gastricAyesendoscopic therapy
749femaleportal venous thrombosisesophageal and gastricAyesmedication

Informed consent was also obtained from all patients before surgery. This study was approved by our institutional review board.

2.2 Procedures

All patients underwent a midline abdominal incision while under general anesthesia. After exploring the abdominal cavity and organs, the portal pressure was measured through the epiploic vein. A mesocaval shunt was then established by a side-to-side anastomosis, restricted to 1-cm – 1.5-cm in length, between the superior mesenteric vein and the inferior vena cava. In one case, an 8-mm in diameter prosthetic (W. L. Gore & Associates, Inc.) shunt was chosen because of the high-tension anastomosis between the two vessels. This was followed by exposing the gastric varices and foam sclerosant made up of 2-mL of 1% or 3% polidocanol (Aethoxysklerol, Kreussler, Germany) mixed with 8-mL of air by using the Tessari method was injected into the varices with a 10-mL syringe [10] (Figure 1a, 1b). Soon after the injection, the puncture site vessel was ligated. Normally, 2-mL or 4-mL of 1% polidocanol are administrated to each varicose vein. However, if the varices exceed 6-mm in diameter, 3% polidocanol is applied. In one case, Sclerosant injection was assisted by introducing a catheter through the inferior mesenteric vein to the distal varices (Figure 2a, 2b). Finally, the portal pressure was measured again before closing the incision.

Figure 1 Varicose veins before and after foam injection. a) Varicose veins at lesser gastric curvature (arrow). b) Occlusion of varicose veins after injection of Polidocanol foam.
Figure 1

Varicose veins before and after foam injection. a) Varicose veins at lesser gastric curvature (arrow). b) Occlusion of varicose veins after injection of Polidocanol foam.

Figure 2 Rectal varices before and after foam injection. a) Rectal varices (arrow) at intra-operative angiography via inferior mesenteric vein. b) Occlusion of rectal varicose veins after injection of Polidocanol foam..
Figure 2

Rectal varices before and after foam injection. a) Rectal varices (arrow) at intra-operative angiography via inferior mesenteric vein. b) Occlusion of rectal varicose veins after injection of Polidocanol foam..

2.3 Investigation and follow up

We reviewed the medical records of the 7 patients retrospectively. All patients underwent enhanced CT with or without endoscopic review within two weeks postoperatively and around six months after surgery. Laboratory tests, including liver function, routine blood tests, and blood ammonia levels were all obtained during hospital admission and outpatient reviews. Surgical success was defined as completion of the shunt surgery combined with foam sclerotherapy, without operation related deaths.

Meanwhile, treatment success was defined as an obvious decrease of the varices and an unobstructed shunt on CT or endoscopic reexamination and no variceal re-bleeding during the follow-up period. The free of variceal bleeding time and survival time were measured from surgery until the date the incident occurred or the last outpatient review or telephone contact.

3 Results

All patients underwent shunt surgery combined with foam sclerotherapy with a side-to-side anastomosis mesocaval shunt, except for one patient who received a prosthetic mesocaval shunt. Additionally, 1% polidocanol foam was injected into the gastric varices in seven patients; one of them was simultaneously injected with 3% polidocanol foam via a catheter inserted into the inferior mesenteric vein to seal the rectal varicose vein. The dosage of polidocanol injection ranged from 8-mL to 20-mL (average 12.1-mL). Surgical success was achieved in all patients, with no operative death.

Gastric bleeding occurred in one patient three days after surgery because of fundal ulcer formation, which was confirmed by endoscopic examination and was relieved by acid suppression and blood transfusion. Thrombocytopenia was observed in one patient postoperatively, leading to uncontrolled nasal bleeding. This was managed by plasma transfusion and local hemostasis therapy. No sclerotherapy-related complications were found postoperatively.

The follow-up time ranged from 12 to 24 months (average 15.7 months). During follow up, obvious reduction or eradication of the gastroesophageal varices was observed in three patients; obviously decreased gastric varices but residual esophageal varices was also observed in four patients (Figure 3a, 3b). The patient with rectal varices was found to have obviously decreased varices by colonoscopy; moreover, all shunts were patent until the last CT review. Therefore, treatment success was also achieved in all patients.

Figure 3 Preoperative and reviewed enhanced CT or endoscopy images. a) Gastroesophageal varices at preoperative enhanced CT or endoscopy in 7 patients (arrows). b) Enhanced CT or endoscopy review of the 7 patients showing obviously decreased or eradicated gastric varices in all patients but residual esophageal varices in patient 3,4,5 and 7 after procedure (arrows).
Figure 3

Preoperative and reviewed enhanced CT or endoscopy images. a) Gastroesophageal varices at preoperative enhanced CT or endoscopy in 7 patients (arrows). b) Enhanced CT or endoscopy review of the 7 patients showing obviously decreased or eradicated gastric varices in all patients but residual esophageal varices in patient 3,4,5 and 7 after procedure (arrows).

Lastly, encephalopathy presenting with lethargy was found to have occurred in one patient two months postoperatively and was relieved by ammonia-lowering and lactulose treatment without recurrence. No variceal re-bleeding occurred after surgery, and all patients were alive at the last follow-up time (Table 2).

Table 2

Postoperative results

Post-surgery varicesComplicationsFree of bleeding time (months)
Patient No.Shunt typeSclerosant injection siteFoam volume (mL)Review
CTEndoscopyGastricEsophageal
1mesocavalgastric vein15yesrefusedecreasedecreaseno24
2mesocaval prosthetic graftgastric vein10yesyeseradicationeradicationno17
3mesocavalgastric vein8yesrefusedecreasepersistenceno16
4mesocavalgastric vein10yesyeseradicationpersistenceno14
5mesocavalgastric vein and inferior mesenteric vein20yesyesdecrease of gastric and rectal varicespersistenceencephalopathy14
6mesocavalgastric vein12yesyesdecreasedecreasegastric ulcer13
7mesocavalgastric vein10yesyeseradicationpersistencethrombocytopenia12

4 Discussion

It is recognized that endoscopic therapy, including endoscopic variceal ligation and endoscopic sclerotherapy, is the first management choice for variceal hemorrhage caused by portal hypertension. However, recurrence of variceal bleeding is common and occurs in up to 70% of patients following medical and endoscopic treatment [11]. In addition, endoscopic treatment is not as effective for gastric varices as it is for esophageal varices [12], and the risk of re-bleeding is significantly higher [13]. When endoscopic therapy is difficult or fails, TIPS or other interventional treatment, surgery, or liver transplantation can be effective methods to prevent gastric varices re-bleeding. Although TIPS can reduce the re-bleeding rate and is minimally invasive [14], the high occlusion rate is still a concern.

In a prospective randomized trial of 140 patients with Child-Pugh class A or B liver function the results revealed that distal splenorenal shunt and TIPS had similar rates of re-bleeding, encephalopathy, and survival. However, the rate of thrombosis, stenosis, and reintervention were much higher for TIPS (82%) than distal splenorenal shunt (11%) [7]. Liver transplantation seemed to be an ideal treatment for cirrhotic portal hypertension but this is limited by the short supply of donor livers.

Nowadays, both shunt and non-shunt surgeries are still used to prevent recurrent variceal bleeding. Shunt surgery is an effective method for decompression and hemorrhage prevention, although encephalopathy is a concern. Non-shunt surgery, including several types of devascularization, has a certain effect on hemostasis but a relatively high rate of variceal recurrence and re-bleeding due to unresolved high pressure in the portal venous system [15, 16, 17]. Considering their advantages and disadvantages, many surgeons have performed complex combined shunt and devascularization surgeries.

Feng et al [18]. performed a mesocaval C graft shunt, ligation of the gastric and coronary vein, and partial splenectomy in 140 patients. Their results were encouraging, as 100 patients were followed up for one month to six years, with no recurrent hemorrhage or encephalopathy. At our hospital, we have performed combined surgery for the past five years. Owing to most of our patients being diagnosed with portal venous thrombosis or cavernoma, we usually perform a mesocaval shunt procedure. To avoid excessive shunt flow causing encephalopathy, the shunt anastomosis was restricted of 1 to 1.5-cm in length, or an 8-mm graft was used to maintain sufficient hepatic blood flow. Since its decompressing effect was less than that of total shunt, combined gastric varices devascularization was a complementary method to ensure prevention of variceal re-bleeding.

However, an effective devascularization procedure is sometimes needed to extend the surgical field to expose the gastric fundus and esophagus, which may lead to increased trauma. To simplify the procedure, we attempted to substitute foam sclerotherapy for devascularization because of the following reasons: foam sclerosant not only occludes the main gastric vessel but also occludes the collaterals, even extending to the esophageal vessels; some distal vessels such as rectal varices that are difficult to expose can be managed by catheter-guided sclerotherapy; the technique is easy to master; and Polidocanol foam is proved to be an effective and safe sclerosant used in the varicose veins of the lower extremities [19,20]. Compared with liquid sclerosants, polidocanol foam can reduce the amount of sclerosant needed and maximize the intimal irritation, causing vessel occlusion by increasing the contact surface area with the wall of the varices.

In terms of safety and efficacy, there were few complications reported after foam sclerotherapy with the recommended dose (2-mg/kg/day) by the manufacturer [21,22], even with greater doses than what is recommended [23]. Several studies have shown polidocanol to be as effective as other sclerosants for the treatment of both esophageal and gastric varices [24,25]. There are reports of polidocanol foam used for balloon-occluded retrograde transvenous obliteration of varices via a gastrorenal shunt. The gastric variceal obliteration rate was from 91% to 100%, and re-bleeding occurred in one case during follow up. No severe sclerotherapy-related complications were observed [26, 27, 28].

In our study, gastroesophageal varices were obviously decreased or eradicated in three patients postoperatively.

Although the other four cases had a decrease only in the gastric varices, it solved the problem, which often is the cause of re-bleeding after treatment. Following surgery, gastric bleeding occurred in one patient. However, endoscopy confirmed that this was not variceal bleeding but rather ulcer formation following endoscopic glue obturation, which had been reported as a severe complication related to glue embolization [29,30]. Despite this, no sclerosant-related complications were observed, and no recurrent variceal hemorrhage occurred during follow up, demonstrating that there is effectiveness and safety of shunt surgery combined with foam sclerotherapy.

This preliminary study was limited by its small sample size and the short-term outcomes. Due the domination of endoscopic therapy and interventional treatment, the demand for surgery has reduced considerably. However, based on the large number of patients in China, there are still enough patients suited for surgical treatment, which implies that large samples of patients may require such method in the future. Furthermore, a long-term investigation to monitor re-bleeding, encephalopathy, and survival rate should be continue.

5 Conclusion

Polidocanol foam injection of the varices is simpler in operating than conventional devascularization and provides confirmed variceal obliteration. The outcomes of foam sclerotherapy during shunt surgery indicates short-term efficacy and safety for preventing variceal re-bleeding, with a low complication rate. Further investigation of long-term results in a large sample should be undertaken.

Acknowledgments

None.

  1. Conflict of interest

    Conflict of interest statement: Authors state no conflict of interest.

References

[1] Robertson M., Hayes P., Management of portal hypertension, Budd–Chiari syndrome and portal vein thrombosis, Medicine, 2015, 43(11), 669-673, 10.1016/j.mpmed.2015.08.016Search in Google Scholar

[2] de Franchis R., Primignani M., Natural history of portal hypertension in patients with cirrhosis, Clin Liver Dis, 2001, 5(3), 645-663, 10.1016/S1089-3261(05)70186-0Search in Google Scholar

[3] Chalasani N., Kahi C., Francois F., Pinto A., Marathe A., Bini EJ., et al., Improved patient survival after acute variceal bleeding: a multicentre, cohort study, Am J Gastroenterol, 2003, 98(3), 653-659, 10.1016/S0002-9270(02)06016-1Search in Google Scholar

[4] Wright A.S., Rikkers L.F., Current management of portal hypertension, J Gastrointest Surg, 2005, 9(7), 992-1005, 10.1016/j.gassur.2004.09.028Search in Google Scholar PubMed

[5] Khanna R., Sarin S.K., Non-cirrhotic portal hypertension-diagnosis and management, J Hepatol, 2014, 60(2), 421-441, 10.1016/j.jhep.2013.08.013Search in Google Scholar PubMed

[6] Sarin S.K., Kumar A., Chawla Y.K., Baijal S.S., Dhiman R.K., Jafri W., et al., Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment, Hepatol Int, 2007, 1(3), 398-413, 10.1007/s12072-007-9010-9Search in Google Scholar PubMed PubMed Central

[7] Henderson J.M., Boyer T.D., Kutner M.H., Galloway J.R., Rikkers L.F., Jeffers L.J., et al., DIVERT Study Group. Distal splenorenal shunt versus transjugular intrahepatic portal-systematic shunt for variceal bleeding: a randomized trial, Gastroenterology, 2006, 130(6), 1643-1651, 10.1053/j.gastro.2006.02.008Search in Google Scholar PubMed

[8] Mercado M.A., Surgical treatment for portal hypertension, Br J Surg, 2015, 102(7), 717-718, 10.1002/bjs.9849Search in Google Scholar PubMed

[9] Pal S., Current role of surgery in portal hypertension, Indian J Surg, 2012, 74, 55–66, 10.1007/s12262-011-0381-8Search in Google Scholar PubMed PubMed Central

[10] Tessari L., Cavezzi A., Frullini A., Preliminary experience with a new sclerosing foam in the treatment of varicose veins, Dermatol Surg, 2001, 27(1), 58-60, 10.1111/j.1524-4725.2001.00192.xSearch in Google Scholar

[11] Burroughs A.K., The natural history of varices, J Hepatol, 1993, 17(Suppl 3), 510-513, 10.1016/S0168-8278(05)80448-9Search in Google Scholar

[12] Kapoor A., Dharel N., Sanyal A.J., Endoscopic Diagnosis and Therapy in Gastroesophageal Variceal Bleeding, Gastrointest Endosc Clin N Am, 2015, 25(3), 491-507, 10.1016/j.giec.2015.03.004Search in Google Scholar

[13] Weilert F., Binmoeller K.F., Endoscopic management of gastric variceal bleeding, Gastroenterol Clin North Am, 2014, 43(4), 807-818, 10.1016/j.gtc.2014.08.010Search in Google Scholar

[14] Papatheodoridis G.V., Goulis J., Leandro G., Patch D., Burroughs A.K., Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis, Hepatology, 1999, 30(3), 612-622, 10.1016/j.gtc.2014.08.010Search in Google Scholar

[15] Keagy B.A., Schwartz J.A., Johnson G., Should ablative operations be used for bleeding esophageal varices?, Ann Surg, 1986, 203(5), 463-469, 10.1097/00000658-198605000-00003Search in Google Scholar

[16] Burroughs A.K., Hamilton G., Phillips A., Mezzanotte G., McIntyre N., Hobbs K.E., A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices, N Engl J Med, 1989, 321(13), 857-862, 10.1056/NEJM198909283211303Search in Google Scholar

[17] Jin G., Rikkers L.F., Transabdominal esophagogastric devascularization as treatment for variceal hemorrhage, Surgery, 1996, 120(4), 641-647, 10.1016/S0039-6060(96)80011-0Search in Google Scholar

[18] Feng L.S., Li K., Peng Q.P., Ma X.X., Zhao Y.F., Xu P.Q., et al., Triplex operation for portal hypertension with esophageal variceal bleeding: report of 140 cases, Hepatobiliary Pancreat Dis Int, 2004, 3(4), 534-537Search in Google Scholar

[19] Guex J.J., Foam sclerotherapy: an overview of use for primary venous insufficiency, Semin Vasc Surg, 2005, 18(1), 25-29, 10.1053/j.semvascsurg.2004.12.008Search in Google Scholar

[20] Alòs J., Carreño P., López J.A., Estadella B., Serra-Prat M., Marinel-Lo J., Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial, Eur J Vasc Endovasc Surg, 2006, 31(1), 101-107, 10.1016/j.ejvs.2005.08.018Search in Google Scholar

[21] Conrad P., Malouf G., Stacey M., The Australian polidocanol (Aethoxysklerol) study, Dermatol Surg, 2008, 21(4), 334–336, 10.1016/1076-0512(94)00282-USearch in Google Scholar

[22] Goldman M.P., Treatment of varicose and telangiectatic leg veins: double-blind prospective comparative trial between aethoxyskerol and sotradecol, Dermatol Surg, 2002, 28(1), 52-55, 10.1046/j.1524-4725.2002.01190.xSearch in Google Scholar

[23] Mimura H., Fujiwara H., Hiraki T., Gobara H., Mukai T., Hyodo T., et al., Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief, Eur Radiol, 2009, 19(10), 2474-2480, 10.1007/s00330-009-1442-1442Search in Google Scholar

[24] Bhargava D., Singh B., Dogra R., Dasarathy S., Sharma M.P., Prospective randomized comparison of sodium tetradecyl sulfate and polidocanol as variceal sclerosing agents, Am J Gastroenterol, 1992, 87(2), 182-186Search in Google Scholar

[25] Ravi M., Kate V., Ananthakrishnan N., Prospective randomized comparison of sodium tetradecyl sulphate & polidocanol for oesophageal variceal sclerotherapy, Indian J Med Res, 2001, 113, 228-233Search in Google Scholar

[26] Clements W., Cavanagh K., Ali F., Kavnoudias H., Kemp W., Roberts S., et al., Variant treatment for gastric varices with polidocanol foam using balloon-occluded retrograde transvenous obliteration: a pilot study, J Med Imaging Radiat Oncol, 2012, 56(6), 599-605, 10.1111/j.1754-9485.2012.02453.xSearch in Google Scholar

[27] Koizumi J., Hashimoto T., Myojin K., Itou C., Kagawa T., Nishibe T., et al., Balloon-occluded retrograde transvenous obliteration of gastric varices: use of CT-guided foam sclerotherapy to optimize technique, AJR Am J Roentgenol, 2012, 199(1), 200-207, 10.2214/AJR.11.7002Search in Google Scholar

[28] Choi S.Y., Won J.Y., Kim K.A., Lee D.Y., Lee K.H., Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO), Eur Radiol, 2011, 21(1), 122-129, 10.1007/s00330-010-1895-3Search in Google Scholar

[29] El Amin H., Abdel Baky L., Sayed Z., Abdel Mohsen E., Eid K., Fouad Y., et al., A randomized trial of endoscopic variceal ligation versus Cyanoacrylate injection for treatment of bleeding junctional varices, Trop Gastroenterol, 2010, 31(4), 279-284, 10.1016/S0168-8278(10)60843-4Search in Google Scholar

[30] Cheng L.F., Wang Z.Q., Li C.Z., Lin W., Yeo A.E., Jin B., Low incidence of complications from endoscopic gastric variceal obturation with butyl cyanoacrylate, Clin Gastroenterol Hepatol, 2010, 8(9), 760-766, 10.1016/j.cgh.2010.05.019Search in Google Scholar PubMed

Received: 2017-6-16
Accepted: 2017-9-10
Published Online: 2017-11-22

© 2017 Zhe Zhang et al.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Articles in the same Issue

  1. Regular Articles
  2. Intravascular treatment of left subclavian artery aneurysm coexisting with aortic coarctation in an adult patient
  3. Regular Articles
  4. Effect of electrical stimulation on blood flow velocity and vessel size
  5. Regular Articles
  6. Live birth pregnancy outcome after first in vitro fertilization treatment in a patient with Systemic Lupus Erythematosus and isolated high positive IgA anti-β2glycoprotein I antibodies: a case report
  7. Regular Articles
  8. Periodontal ligament stem cells regulate apoptosis of neutrophils
  9. Regular Articles
  10. Platelet-rich fibrin (PRF) in implants dentistry in combination with new bone regenerative flapless technique: evolution of the technique and final results
  11. Regular Articles
  12. The significance of strong ion gap for predicting return of spontaneous circulation in patients with cardiopulmonary arrest
  13. Regular Articles
  14. Clinicopathology of EpCAM and EGFR in human epithelial ovarian carcinoma
  15. Regular Articles
  16. Intraosseous lipoma of the mandibula: A case report and review of the literature
  17. Regular Articles
  18. Transurethral resection of the prostate, bladder explosion and hyponatremic encephalopathy: a rare case report of malpractice
  19. Regular Articles
  20. Brain strokes related to aortic aneurysma – the analysis of three cases
  21. Regular Articles
  22. Effect of Bicyclol tablets on drug induced liver injuries after kidney transplantation
  23. Regular Articles
  24. Plasma free fatty acids in hyperemesis gravidarum pregnancy
  25. Regular Articles
  26. Impact of chromosomal rearrangement upon DNA methylation patterns in leukemia
  27. Regular Articles
  28. Gefitinib versus docetaxel in treated non-small-cell lung cancer: a meta-analysis
  29. Regular Articles
  30. The clinical characteristics of patients with chronic idiopathic anal pain
  31. Regular Articles
  32. Bone tunnel impaction reduced the tibial tunnel enlargement
  33. Regular Articles
  34. Effects of S-1 combined with radiotherapy in the treatment of nasopharyngeal cancer: a meta-analysis based on randomized controlled trials
  35. Regular Articles
  36. Predictions and outcomes of atrial fibrillation in the patients with acute myocardial infarction
  37. Regular Articles
  38. An accuracy study of the Intracavitary Electrocardiogram (IC-ECG) guided peripherally inserted central catheter tip placement among neonates
  39. Regular Articles
  40. Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: A meta-analysis
  41. Regular Articles
  42. Surface coil intensity correction in magnetic resonance imaging in spinal metastases
  43. Regular Articles
  44. Muscle stem cell and physical activity: what point is the debate at?
  45. Regular Articles
  46. MicroRNA let-7g directly targets forkhead box C2 (FOXC2) to modulate bone metastasis in breast cancer
  47. Regular Articles
  48. Monitoring health inequalities at the municipal level: Lithuanian experience
  49. Regular Articles
  50. Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
  51. Regular Articles
  52. Thrombectomy combined with indwelling-catheter thrombolysis is more effective than pure thrombectomy for the treatment of lower extremity deep venous thrombosis
  53. Regular Articles
  54. Expression of Hepcidin and Neogenin in colorectal cancer
  55. Regular Articles
  56. Carnitine and adiponectin levels in breast cancer after radiotherapy
  57. Regular Articles
  58. Pathophysiology of meningioma growth in pregnancy
  59. Regular Articles
  60. Causal neuro-immune relationships at patients with chronic pyelonephritis and cholecystitis. Correlations between parameters EEG, HRV and white blood cell count
  61. Regular Articles
  62. Measuring efficiency of secondary healthcare providers in Slovenia
  63. Regular Articles
  64. Galectin-3 expression in colorectal cancer and its correlation with clinical pathological characteristics and prognosis
  65. Regular Articles
  66. Model for studying anti- allergic drugs for allergic conjunctivitis in animals
  67. Regular Articles
  68. Barriers perceived by nurses in the optimal treatment of postoperative pain
  69. Regular Articles
  70. Tumor microenvironment in treatment of glioma
  71. Regular Articles
  72. Delirium risk of dexmedetomidine and midazolam in patients treated with postoperative mechanical ventilation: A meta-analysis
  73. Regular Articles
  74. Hemangioma of the rib: a rare case report and literature review
  75. Regular Articles
  76. The diagnostic accuracy of conventional forceps biopsy compared to ESD
  77. Regular Articles
  78. Increased miR-25 expression in serum of gastric cancer patients is correlated with CA19-9 and acts as a potential diagnostic biomarker
  79. Regular Articles
  80. Therapeutic nanomedicine surmounts the limitations of pharmacotherapy
  81. Regular Articles
  82. Relationship between PD-L1 expression and clinical characteristics in patients with breast invasive ductal carcinoma
  83. Regular Articles
  84. Trypsinogen activation peptide induces HMGB1 release from rat pancreatic acinar cells
  85. Regular Articles
  86. The effective regulation of pro- and anti-inflammatory cytokines induced by combination of PA-MSHA and BPIFB1 in initiation of innate immune responses
  87. Regular Articles
  88. Cell based therapeutic approach in vascular surgery: application and review
  89. Regular Articles
  90. Clinical efficacy of alprostadil combined with α-lipoic acid in the treatment of elderly patients with diabetic nephropathy
  91. Regular Articles
  92. Professional burnout and concurrent health complaints in neonatal nursing
  93. Regular Articles
  94. Esophageal xanthoma: presence of M2 macrophages suggests association with late inflammatory and reparative processes
  95. Regular Articles
  96. Cone beam computed tomography analysis in 3D position of maxillary denture
  97. Regular Articles
  98. CK20 mRNA expression in serum as a biomarker for colorectal cancer diagnosis: A meta-analysis
  99. Regular Articles
  100. Serum AFU, 5’-NT and AFP as biomarkers for primary hepatocellular carcinoma diagnosis
  101. Regular Articles
  102. Absolute reliability and concurrent validity of hand held dynamometry and isokinetic dynamometry in the hip, knee and ankle joint: systematic review and meta-analysis
  103. Regular Articles
  104. The Fountain of Youth: A tale of parabiosis, stem cells, and rejuvenation
  105. Regular Articles
  106. Foam sclerotherapy during shunt surgery for portal hypertension and varices
  107. Regular Articles
  108. Insomnia and depression: Japanese hospital workers questionnaire survey
  109. Regular Articles
  110. Serum NF-κBp65, TLR4 as biomarker for diagnosis of preeclampsia
  111. Regular Articles
  112. Docetaxel/cisplatin therapy in myasthenia gravis with hypertension/diabetes
  113. Regular Articles
  114. Fluid resuscitation and markers of glycocalyx degradation in severe sepsis
  115. Regular Articles
  116. Modified Sauve-Kapandji procedure for patients with old fractures of the distal radius
  117. Regular Articles
  118. Bile leakage after liver transplantation
  119. Regular Articles
  120. VEGF overexpression predicts poor survival in hepatocellular carcinoma
  121. Regular Articles
  122. Galen vein aneurysm– challenge for treatment
  123. Regular Articles
  124. Retrieval of a broken sewing needle from the sacrum aided by a permanent magnet: a case report and literature review
  125. Regular Articles
  126. HIV/STI prevention interventions: A systematic review and meta-analysis
  127. Regular Articles
  128. Aortic aneurysm as a complication of myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis
  129. Regular Articles
  130. Real-time monitoring of contrast-enhanced ultrasound for radio frequency ablation
  131. Regular Articles
  132. Successful drug-eluting stent implantation in a male patient with dextrocardia: a case report
  133. Regular Articles
  134. Primary pleomorphic liposarcoma of fallopian tube with recurrence: a case report and review of the literature
  135. Regular Articles
  136. Color Doppler Ultrasound in Uterine Arterial Embolization
  137. Regular Articles
  138. Pattern of alcohol consumption by young people from North Eastern Portugal
  139. Regular Articles
  140. Effects of out-of-hospital continuing nursing on schizophrenia patients' rehabilitation and quality of life
Downloaded on 25.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/med-2017-0055/html
Scroll to top button